AGA Clinical Practice Update on Interaction Between Oral Direct‐Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review

Lignende værker

• AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
  af: Singal, Amit G., et al.
  Udgivet: (2019)
• Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
  af: Kanwal, Fasiha, et al.
  Udgivet: (2019)
• Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
  af: Chen, Qiushi, et al.
  Udgivet: (2020)
• Hepatitis C Disease Burden in the United States in the Era of Oral Direct-Acting Antivirals
  af: Chhatwal, Jagpreet, et al.
  Udgivet: (2016)
• Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
  af: Kamp, William M., et al.
  Udgivet: (2019)